Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANGEL-ASPECT: Endovascular Therapy in Large Infarct Core
NCT04551664Completed
- Sponsor
- Beijing Tiantan Hospital
- Start
- Oct 2020
- Primary completion
- Aug 2022
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: modified Rankin Scale at 90 days. Started Oct 2020; status: completed.
Beyond the preview
Go deeper on NCT04551664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04551664.